Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-chloro-6alpha, 9-difluoro-11beta, 17,21-trihydroxy-16alpha-methylpregna-1,4-dien-3,20-dione
2. C 48,401-ba
3. C-48,401-ba
4. Halometasone Monohydrate
5. Sicorten
1. 50629-82-8
2. 2-chloroflumethasone
3. Halometasone [inn]
4. Halometasone Monohydrate
5. Halometasone Hydrate
6. J69z9uu41z
7. Halometasone (inn)
8. Pregna-1,4-diene-3,20-dione, 2-chloro-6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)-
9. Halometasona
10. Halometasonum
11. Smr000466330
12. Halometasonum [inn-latin]
13. Halometasona [inn-spanish]
14. Unii-j69z9uu41z
15. (6s,8s,9r,10s,11s,13s,14s,16r,17r)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
16. Einecs 256-664-9
17. Halometasone [mi]
18. Schembl4872
19. Halometasone [mart.]
20. Mls000759439
21. Mls001424089
22. Halometasone [who-dd]
23. Chembl1587228
24. Dtxsid1048382
25. Chebi:135724
26. Hms2051c16
27. Hms2232n17
28. Zinc3938673
29. Akos025402048
30. Ac-3528
31. Ccg-100880
32. Db13728
33. Nc00130
34. 2-chlor-6alpha,9-difluor-11beta,17,21-trihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dion
35. As-78199
36. Cs-0453061
37. D07202
38. Ab00639905-06
39. 629h828
40. Q-101370
41. Q10910139
42. (6s,8s,9r,10s,11s,13s,14s,16r,17r)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one
43. 2-chloro-6.alpha.,9-difluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione
44. 2-chloro-6alpha,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
Molecular Weight | 444.9 g/mol |
---|---|
Molecular Formula | C22H27ClF2O5 |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 444.1515080 g/mol |
Monoisotopic Mass | 444.1515080 g/mol |
Topological Polar Surface Area | 94.8 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 889 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07A - Corticosteroids, plain
D07AC - Corticosteroids, potent (group iii)
D07AC12 - Halometasone
Global Sales Information
Market Place
ABOUT THIS PAGE
A Halometasone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halometasone, including repackagers and relabelers. The FDA regulates Halometasone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halometasone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Halometasone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Halometasone supplier is an individual or a company that provides Halometasone active pharmaceutical ingredient (API) or Halometasone finished formulations upon request. The Halometasone suppliers may include Halometasone API manufacturers, exporters, distributors and traders.
click here to find a list of Halometasone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Halometasone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Halometasone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halometasone GMP manufacturer or Halometasone GMP API supplier for your needs.
A Halometasone CoA (Certificate of Analysis) is a formal document that attests to Halometasone's compliance with Halometasone specifications and serves as a tool for batch-level quality control.
Halometasone CoA mostly includes findings from lab analyses of a specific batch. For each Halometasone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Halometasone may be tested according to a variety of international standards, such as European Pharmacopoeia (Halometasone EP), Halometasone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halometasone USP).
LOOKING FOR A SUPPLIER?